NCT05850468

Brief Summary

opioid free anesthesia consists of combination of pharmacological and non pharmacological modalities that target different pathways of pain mechanism. combining myofascial plane blocks with infusion of adjuvants such as lidocaine or dexmedetomidine can offer equivalent intraoperative hemodynamic stability compared to that of opioid with better pain control postoperatively. this study will investigate the efficacy of combined erector spina block with lidocaine and dexmedetomidine infusion as opioid sparing anesthesia in spine surgeries

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

May 9, 2023

Status Verified

March 1, 2023

Enrollment Period

5 months

First QC Date

March 18, 2023

Last Update Submit

April 29, 2023

Conditions

Keywords

multimodal analgesia, regional blocks, spine surgeries

Outcome Measures

Primary Outcomes (2)

  • number of patients (percentage) having intraoperative systolic hypertension

    blood pressure more than 160 mmhg

    during operation(intraoperatively)

  • number of patients(percentage) having tachycardia

    heart rate more than 100 beat /minute

    during operation(intraoperatively)

Secondary Outcomes (2)

  • VAS score

    every 30 minutes for 2 hours postoperatively

  • incidence of bradycardia

    intraoperatively

Study Arms (2)

traditinal balanced anesthesia

ACTIVE COMPARATOR

fentanyl infusion after general anesthesia and erector spinea block

Drug: fentanyl infusion after general anesthesia and erector spinea block

opioid free anesthesia

EXPERIMENTAL

lidocaine and dextometidine infusion after general anesthesia and erector spinea block

Drug: lidocaine 2% and dextometometidine infusion after general anesthesia and erector spinea block

Interventions

intraoperative opioid infusion in active comparative group

Also known as: opioid infusion
traditinal balanced anesthesia

intraoperative non opioid infusion in experimental group

Also known as: lidocaine 2% and precedex infusion
opioid free anesthesia

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- spine surgery ASAI,II

You may not qualify if:

  • revision surgery hypotension bradycardia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ainshams hospitals

Cairo, 11591, Egypt

Location

Related Publications (1)

  • Rowland M, Thomson PD, Guichard A, Melmon KL. Disposition kinetics of lidocaine in normal subjects. Ann N Y Acad Sci. 1971 Jul 6;179:383-98. doi: 10.1111/j.1749-6632.1971.tb46915.x. No abstract available.

    PMID: 5285383BACKGROUND

MeSH Terms

Interventions

Lidocaine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • sanaa wasfy, professor

    assistant professor of anesthesia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

sanaa wasfy, professor

CONTACT

wael behairy, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2023

First Posted

May 9, 2023

Study Start

May 1, 2023

Primary Completion

October 1, 2023

Study Completion

November 1, 2023

Last Updated

May 9, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations